ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 104 filers reported holding ENDOLOGIX INC in Q4 2017. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $132,000 | -65.9% | 183,818 | -9.2% | 0.00% | – |
Q3 2018 | $387,000 | -62.1% | 202,537 | +12.4% | 0.00% | -100.0% |
Q2 2018 | $1,020,000 | +38.8% | 180,189 | +3.7% | 0.00% | 0.0% |
Q1 2018 | $735,000 | -19.6% | 173,813 | +1.7% | 0.00% | 0.0% |
Q4 2017 | $914,000 | +57.6% | 170,868 | +31.5% | 0.00% | 0.0% |
Q3 2017 | $580,000 | +51.0% | 129,945 | +64.5% | 0.00% | – |
Q2 2017 | $384,000 | -40.9% | 78,975 | -12.0% | 0.00% | -100.0% |
Q1 2017 | $650,000 | +64.6% | 89,748 | +30.0% | 0.00% | 0.0% |
Q4 2016 | $395,000 | -55.0% | 69,063 | +0.8% | 0.00% | 0.0% |
Q3 2016 | $877,000 | -20.1% | 68,529 | -22.2% | 0.00% | -50.0% |
Q2 2016 | $1,098,000 | +131.6% | 88,108 | +55.5% | 0.00% | +100.0% |
Q1 2016 | $474,000 | +159.0% | 56,673 | +207.2% | 0.00% | – |
Q4 2015 | $183,000 | -57.0% | 18,448 | -46.9% | 0.00% | -100.0% |
Q3 2015 | $426,000 | -23.1% | 34,719 | -3.8% | 0.00% | 0.0% |
Q2 2015 | $554,000 | -16.8% | 36,107 | -7.4% | 0.00% | 0.0% |
Q1 2015 | $666,000 | +16.0% | 39,002 | +3.9% | 0.00% | 0.0% |
Q4 2014 | $574,000 | +89.4% | 37,554 | +31.6% | 0.00% | 0.0% |
Q3 2014 | $303,000 | -32.2% | 28,543 | -2.9% | 0.00% | 0.0% |
Q2 2014 | $447,000 | +11.5% | 29,392 | -5.6% | 0.00% | 0.0% |
Q1 2014 | $401,000 | -23.9% | 31,139 | +3.0% | 0.00% | 0.0% |
Q4 2013 | $527,000 | +16.6% | 30,231 | +8.0% | 0.00% | 0.0% |
Q3 2013 | $452,000 | +34.9% | 27,996 | +11.1% | 0.00% | 0.0% |
Q2 2013 | $335,000 | – | 25,209 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|